LINDSAY GONZALEZ: Open Payments
NPI 1538481601 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,329 in 53 payments from 19 companies in 2025. Trend: 2023 $915 · 2024 $906 · 2025 $1,329
Food & beverage: $1,245Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $296 |
| ABBVIE INC. | 4 | $199 |
| Ardelyx, Inc. | 4 | $119 |
| Lilly USA, LLC | 5 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90 |
| GENZYME CORPORATION | 3 | $70 |
| PFIZER INC. | 3 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $63 |
| Celltrion USA Inc. | 2 | $56 |
| Novo Nordisk Inc | 2 | $45 |
Products named: TREMFYA, RINVOQ, IBSRELA, DUPIXENT, VELSIPITY, ENTYVIO, XIFAXAN, JARDIANCE.
Industry payments across MD — which companies pay providers there.
